Book Section #17705

Stimuli-responsive nanocarriers have emerged as an advanced approach in novel drug delivery systems aimed at achieving controlled and site-specific drug release. These intelligent nanocarriers are engineered to respond to specific internal or external stimuli such as variations in pH, temperature, enzymatic activity, light, or magnetic fields. Upon exposure
to these stimuli, the nanocarrier undergoes structural or physicochemical changes that trigger the release of the encapsulated drug at tHe desired target site. Such targeted release improves therapeutic efficacy while minimizing systemic toxicity and adverse effects associated with
conventional drug delivery. In addition, stimuli-responsive nanocarriers can enhance pharmacokinetic properties by protecting drugs from premature degradation, prolonging
systemic circulation, and enabling more precise drug distribution. These systems have demonstrated promising applications in cancer therapy, inflammatory disorders, and other chronic diseases where targeted and controlled drug delivery is essential. Recent advances in nanotechnology have facilitated the development of multifunctional nanocarriers capable of responding to multiple stimuli, thereby further improving the precision and effectiveness of
drug delivery. Overall, stimuli-responsive nanocarriers represent a promising innovation in pharmaceutical sciences with the potential to significantly enhance therapeutic outcomes and optimize modern pharmacotherapy.